AstraZeneca Vaccine Results Likely By Christmas, With Early Efficacy Findings in Weeks
Researchers at the University of Oxford expect to report results from their phase 3 trials of AstraZeneca’s (AZ) COVID-19 vaccine candidate, AZD1222, before Christmas, the study’s leader said.
Source: Drug Industry Daily